Q2 FY23 Earnings

LargestFastest profit growthFastest sales growth

Sector All sectorsAerospace & DefenseAutomobilesBeveragesCapital GoodsCapital MarketsChemicalsCommercial ServicesCommoditiesConstructionConsumer DiscretionaryConsumer GoodsConsumer ServicesDiversifiedEnergyEngineering ServicesFast Moving Consumer GoodsFinancial ServicesFMCGFood ProductsForest MaterialsHealthcareHealthcare ServicesIndustrial ProductsIndustrialsInformation TechnologyLeisure ServicesLogistics & CargoMediaMetals & MiningOil & GasPetroleum ProductsPowerRealtyRetailServicesTelecomTelecommunicationTextilesTransportUtilities Result Any resultBeatMissedIn lineNo estimate Clear filters 1–25 of 25

Company		Revenue (₹ Cr)			Profit (₹ Cr)		Per share		8Q profit
Symbol	Sector	Reported ↓	YoY	QoQ	Reported	YoY	EPS	vs consensus	Trend
INDSWFTLTD Ind-Swift Ltd	Healthcare	104	n/a	up+9.5%	-11	n/a	-1.95	No estimate
MHHL Mohini Health & Hygiene Ltd	Healthcare	99	up+115.2%	n/a	5	up+150.0%	2.81	No estimate
INFINIUM Infinium Pharmachem Ltd	Healthcare	79	n/a	n/a	6	n/a	5.40	No estimate
SB — Sharon Bio-Medicine Ltd	Healthcare	55	up+21.6%	up+45.8%	9	up+97.5%	0.74	No estimate
HEMANTSURGICALINDUSTRIESLTD Hemant Surgical Industries Ltd	Healthcare	51	n/a	n/a	2	n/a	48.12	No estimate
ADESHWARLTD Adeshwar Meditex Ltd	Healthcare	46	up+52.5%	n/a	1	up+60.3%	0.76	No estimate
MADHAVBAUG Vaidya Sane Ayurved Laboratories Ltd	Healthcare	46	n/a	n/a	3	n/a	2.60	No estimate
CHANDRABHAGATPHARMALTD Chandra Bhagat Pharma Ltd	Healthcare	44	up+2.3%	n/a	0	n/a	0.49	No estimate
SOTAC Sotac Pharmaceuticals Ltd	Healthcare	40	n/a	n/a	2	n/a	6.78	No estimate
CH — Cian Healthcare Ltd	Healthcare	38	down-19.1%	n/a	0	n/a	0.19	No estimate
BHARATIMMUNOLOGICALSBIOLOGICALSCORPORATIONLTD Bharat Immunological & Biological Corporation Ltd	Healthcare	26	up+7.2%	up+152.7%	-3	n/a	-0.71	No estimate
SHELTERPHARMALTD Shelter Pharma Ltd	Healthcare	17	n/a	n/a	2	n/a	49.59	No estimate
WALPAR Walpar Nutritions Ltd	Healthcare	17	up+18.2%	n/a	-0	down-375.0%	-0.42	No estimate
MO MURAEORGANISORLTD Murae Organisor Ltd	Healthcare	7	n/a	up+66.1%	0	n/a	0.00	No estimate
OL — Omega Laboratories Ltd	Healthcare	7	up+52.1%	n/a	0	up+80.0%	0.18	No estimate
SANGANI Sangani Hospitals Ltd	Healthcare	6	n/a	n/a	1	n/a	0.86	No estimate
KMSMEDISURGILTD KMS Medisurgi Ltd	Healthcare	6	up+3.3%	n/a	0	up+116.7%	0.79	No estimate
VILINBIO Vilin Bio Med Ltd	Healthcare	4	n/a	n/a	1	n/a	1.67	No estimate
VANTABIOSCIENCELTD Vanta Bioscience Ltd	Healthcare	3	down-47.6%	n/a	-3	down-12,900.0%	-4.06	No estimate
MD MEDINOVADIAGNOSTICSERVICELTD Medinova Diagnostic Services Ltd	Healthcare	3	n/a	n/a	0	n/a	0.36	No estimate
MD — Medinova Diagnostic Services Ltd	Healthcare	3	n/a	n/a	0	n/a	0.36	No estimate
GANGAPHARMACEUTICALSLTD Ganga Pharmaceuticals Ltd	Healthcare	1	up+8.0%	n/a	0	n/a	0.07	No estimate
CELESTIAL Celestial Biolabs Ltd	Healthcare	0	n/a	down-33.3%	-0	n/a	-0.04	No estimate
TRANSPACTENTERPRISESLTD Transpact Enterprises Ltd	Healthcare	0	n/a	n/a	0	n/a	0.52	No estimate
SH — Secunderabad Healthcare Ltd	Healthcare	0	n/a	n/a	0	n/a	0.00	No estimate

About Q2 FY23 earnings data

When are Q2 FY23 results announced?

Q2 FY23 covers the Jul–Sep 2022 quarter. Indian listed companies have up to 45 days after a quarter closes to file their results — 60 days for the January–March quarter — so results arrive in a wave over the weeks that follow rather than all at once. A quarter that has only just ended will look sparse and fill in.

Why do some Q2 FY23 growth figures show "n/a" instead of a percentage?

Growth is left blank whenever the comparison period was not profitable. A percentage change measured from a loss is arithmetic without meaning — a swing from a ₹10 crore loss to a ₹10 crore profit is not "200% growth", and publishing it as such would flatter the company. The reported figures for both periods are still shown, so the change is there to read directly.

Does the beat/miss verdict cover every company?

No analyst consensus was available for Q2 FY23, so no beat/miss verdict is shown. Revenue and profit growth are taken from reported results and cover every company in the table.

What counts as an in-line result rather than a beat or a miss?

Reported earnings per share within ±2% of the consensus estimate. The band is set there because a tighter one classifies rounding as news, and a wider one swallows surprises that genuinely moved a stock.

Are the figures consolidated or standalone?

Consolidated where a company reports on that basis, standalone otherwise, with all money in ₹ crore. Figures are as filed by the company with the exchanges (NSE/BSE); they are not restated or adjusted.

What does the 8-quarter trend line show?

Quarterly net profit for the last eight quarters, oldest on the left, always ending on the quarter shown in the row. Two years covers both the seasonal shape of the business and its direction. The line breaks where a quarter is missing rather than drawing across the gap, so a break is a real absence of data and not a reported collapse.

How do I find only the companies that beat estimates in Q2 FY23?

Use the Result filter above the table and choose Beat, or sort by EPS surprise to rank every covered company by how far it landed from consensus. Both are reflected in the page URL, so a filtered view can be bookmarked or shared.

Figures are as reported by companies in their quarterly filings to the exchanges (NSE/BSE), in ₹ crore. Consolidated results are shown where a company reports them, otherwise standalone. Year-on-year and quarter-on-quarter growth is omitted where the comparison period was loss-making, since a percentage change from a negative base is not meaningful. Analyst consensus is an estimate, not a forecast of outcome.